Introduction: Following the emergence of SARS-CoV-2 in 2020, care homes were disproportionately impacted by high mortality and morbidity of vulnerable elderly residents. Non-pharmaceutical interventions (NPIs) and improved infection control measures together with vaccination campaigns have since improved outcomes of infection. We studied the utility of past infection status, recent vaccination and anti-S antibody titres as possible correlates of protection against a newly emergent Omicron variant infection.
Methods: Prospective longitudinal surveillance of nine sentinel London care homes from April 2020 onwards found that all experienced COVID-19 outbreaks due to Omicron (BA.1) during December 2021 and January 2022, despite extensive prior SARS-CoV-2 exposure and high COVID-19 vaccination rates, including booster vaccines (>70% residents, >40% staff).
Results: Detailed investigation showed that 46% (133/288) of Omicron BA.1 infections were SARS-CoV-2 reinfections. Two and three COVID-19 vaccine doses were protective against Omicron infection within 2-9 weeks of vaccination, though protection waned from 10 weeks post-vaccination. Prior infection provided additional protection in vaccinated individuals, approximately halving the risk of SARS-CoV-2 infection.
Discussion: Anti-S antibody titre showed a dose-dependent protective effect but did not fully account for the protection provided by vaccination or past infection, indicating that other mechanisms of protection are also involved.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627010 | PMC |
| http://dx.doi.org/10.3389/fimmu.2023.1186134 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study.
Vaccines (Basel)
September 2024
Department of Medicine, McGill University, Montreal, QC H3A 0E9, Canada.
Article Synopsis
- - SARS-CoV-2 is still a major cause of death in North America, and this study examines how methotrexate and tumor necrosis factor inhibitors (TNFi) affect vaccine responses in patients with immune-mediated inflammatory diseases (IMID).
- - Researchers collected and analyzed serum samples from 479 adults with conditions like inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) across Canada to evaluate neutralization responses to COVID-19 vaccination.
- - The results indicated that both methotrexate and TNFi independently reduced the ability to neutralize the virus, underscoring the need for careful vaccination strategies as COVID-19 remains widespread.
Evaluation of Vaccine Strategies among Healthcare Workers during COVID-19 Omicron Outbreak in Taiwan.
Vaccines (Basel)
September 2024
Division of Pediatric Infectious Diseases, Departments of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.
Article Synopsis
- This study evaluated the safety and immune response of various COVID-19 vaccines among healthcare workers in Taiwan during the Omicron variant outbreak, comparing their effectiveness.
- Conducted from March 2021 to July 2023, the research involved 710 healthcare workers who received different vaccines, with blood samples taken to measure antibody levels and record side effects.
- Results showed that mRNA vaccines like Moderna offered the highest initial antibody levels and effectiveness, while regular booster doses significantly boosted immunity and reduced COVID-19 cases among workers.
Article Synopsis
- - COVID-19 continues to pose risks to health, including long COVID, necessitating ongoing evaluation of vaccines and immunity against different variants of the virus.
- - A study analyzed immunity levels from vaccines, past infections, and hybrid immunity from December 2021 to August 2023 in Czechia, finding that recent booster vaccination significantly protects against severe COVID-19, while older vaccinations achieve less protection.
- - The study concludes that while vaccination is still effective in preventing severe COVID-19, its effects diminish over time, emphasizing the need for booster shots, and that prior immunity offers limited protection against long COVID after infection.
Nosocomial Outbreak of SARS-CoV-2 in a Hospital Ward during the Omicron Variant-Dominant Wave with a Review of the Relevant Literature.
Jpn J Infect Dis
September 2024
Department of Infectious Diseases, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Japan.
Clusters of nosocomial coronavirus disease 2019 (COVID-19) have been reported globally during the recent pandemic. Unfortunately, these clusters negatively affect inpatient morbidity, mortality, and hospital functioning. Using epidemiological data and whole-genome sequencing (WGS) of SARS-CoV-2, this study investigated the outbreak of COVID-19 at a university hospital.
View Article and Find Full Text PDFPseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage.
PLoS Pathog
May 2024
Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
Pairwise compatibility between virus and host proteins can dictate the outcome of infection. During transmission, both inter- and intraspecies variabilities in receptor protein sequences can impact cell susceptibility. Many viruses possess mutable viral entry proteins and the patterns of host compatibility can shift as the viral protein sequence changes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!